Get the Stockscreener App
0.46
4.15%
-0.0199
After Hours:
1.06
0.60
+130.43%
Pharma-Bio Serv Inc Stock (PBSV) Forecast
The Pharma-Bio Serv Inc (PBSV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.8787, representing a +91.03% increase from the current price of $0.46. The highest analyst price target is $0.9737, and the lowest is $0.7838.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PBSV Price Target
Average 0.9402
(+104.40% Upside)
Long-term PBSV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharma-Bio Serv Inc financial reports and earnings history, Pharma-Bio Serv Inc (PBSV) stock could reach $1.34 by 2030, $1.8407 by 2040 and $2.3413 by 2050. See the projected annual prices until 2050 of the Pharma-Bio Serv Inc stock below:
- Pharma-Bio Serv Inc (PBSV) is expected to reach an average price of $1.4269 in 2035, with a high prediction of $1.5903 and a low estimate of $1.3239. This indicates an $210.19% rise from the last recorded price of $0.46.
- Pharma-Bio Serv Inc (PBSV) stock is projected to chart a bullish course in 2040, with an average price target of $1.7285, representing an $275.77% surge from its current level. The forecast ranges from a conservative $1.6575 to a sky-high $1.8407.
- Our analysts predict Pharma-Bio Serv Inc (PBSV) to jump 332.78% by 2045, soaring from $1.9075 to an average price of $1.9908, potentially reaching $2.091. While $1.9075 is the low estimate, the potential upside is significant.
- Pharma-Bio Serv Inc (PBSV) stock is expected to climb by 2050, reaching an average of $2.242, a $387.39% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.3413 and $2.1787, respectively, highlighting the market's uncertainty.
Pharma-Bio Serv Inc Stock (PBSV) Year by Year Forecast
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2025
Pharma-Bio Serv Inc Stock (PBSV) is expected to reach an average price of $0.9211 in 2025, with a high prediction of $1.1282 and a low estimate of $0.714. This indicates an +100.24% rise from the last recorded price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.9731 | $0.7838 | $0.9737 | +111.55% |
| June, 2025 | $0.9885 | $0.8443 | $1.109 | +114.89% |
| July, 2025 | $0.9156 | $0.8856 | $1.0055 | +99.04% |
| August, 2025 | $0.932 | $0.8666 | $0.9351 | +102.61% |
| September, 2025 | $0.9529 | $0.733 | $0.9923 | +107.16% |
| October, 2025 | $0.9538 | $0.8635 | $1.0219 | +107.34% |
| November, 2025 | $1.0144 | $0.946 | $1.1282 | +120.52% |
| December, 2025 | $0.9053 | $0.905 | $1.0249 | +96.81% |
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2026
The predicted value for Pharma-Bio Serv Inc (PBSV) in 2026 is set at an average of $0.9594. Estimates vary from a peak of $1.1667 to a trough of $0.752, indicating an +108.56% surge from the present price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9214 | $0.752 | $1.0113 | +100.31% |
| February, 2026 | $1.0119 | $0.822 | $1.0119 | +119.99% |
| March, 2026 | $1.027 | $0.8827 | $1.1475 | +123.26% |
| April, 2026 | $1.0241 | $0.9835 | $1.0441 | +122.64% |
| May, 2026 | $0.9748 | $0.9055 | $1.0442 | +111.92% |
| June, 2026 | $0.8681 | $0.771 | $1.0304 | +88.72% |
| July, 2026 | $0.9119 | $0.8412 | $1.0311 | +98.23% |
| August, 2026 | $1.0028 | $0.9844 | $1.1667 | +117.99% |
| September, 2026 | $0.9689 | $0.9437 | $1.0636 | +110.63% |
| October, 2026 | $1.0492 | $0.7901 | $1.0493 | +128.08% |
| November, 2026 | $1.0103 | $0.8601 | $1.0494 | +119.62% |
| December, 2026 | $1.0116 | $0.921 | $1.0795 | +119.92% |
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharma-Bio Serv Inc (PBSV) is $1.0168, with a high forecast of $1.2245 and a low forecast of $0.8091. This indicates an +121.04% increase from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0826 | $1.0221 | $1.186 | +135.34% |
| February, 2027 | $0.9636 | $0.9631 | $1.083 | +109.47% |
| March, 2027 | $0.9788 | $0.8091 | $1.0685 | +112.79% |
| April, 2027 | $1.0689 | $0.8794 | $1.0694 | +132.38% |
| May, 2027 | $1.0848 | $0.9402 | $1.2053 | +135.82% |
| June, 2027 | $1.0124 | $0.9824 | $1.1023 | +120.10% |
| July, 2027 | $1.027 | $0.9638 | $1.0323 | +123.26% |
| August, 2027 | $1.0485 | $0.8281 | $1.0875 | +127.94% |
| September, 2027 | $1.0498 | $0.9594 | $1.1179 | +128.22% |
| October, 2027 | $1.1109 | $1.0421 | $1.2245 | +141.50% |
| November, 2027 | $1.0024 | $1.0018 | $1.1217 | +117.92% |
| December, 2027 | $1.0166 | $0.8471 | $1.1065 | +121.01% |
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2028
In 2028, Pharma-Bio Serv Inc (PBSV) is projected to reach an average price of $1.0742, with a high projection of $1.2823 and a low estimate of $0.8661. This indicates an +133.52% rise from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.1076 | $0.9176 | $1.1076 | +140.79% |
| February, 2028 | $1.1233 | $0.9786 | $1.2438 | +144.19% |
| March, 2028 | $1.1209 | $1.0799 | $1.1409 | +143.67% |
| April, 2028 | $1.0719 | $1.0027 | $1.1411 | +133.02% |
| May, 2028 | $0.9636 | $0.8661 | $1.1256 | +109.48% |
| June, 2028 | $1.0078 | $0.9367 | $1.1268 | +119.08% |
| July, 2028 | $1.0992 | $1.0806 | $1.263 | +138.95% |
| August, 2028 | $1.0659 | $1.0406 | $1.1605 | +131.71% |
| September, 2028 | $1.1443 | $0.8852 | $1.1444 | +148.75% |
| October, 2028 | $1.1459 | $0.9553 | $1.1459 | +149.11% |
| November, 2028 | $1.1078 | $1.017 | $1.1755 | +140.83% |
| December, 2028 | $1.1792 | $1.1184 | $1.2823 | +156.34% |
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2029
The 2029 price forecast for Pharma-Bio Serv Inc Stock (PBSV) is $1.1125 on average, with a high prediction of $1.3208 and a low estimate of $0.9042. This represents an +141.85% increase from the previous price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1107 | $1.0415 | $1.1798 | +141.45% |
| February, 2029 | $1.0742 | $0.9042 | $1.1637 | +133.52% |
| March, 2029 | $1.1648 | $0.975 | $1.1651 | +153.21% |
| April, 2029 | $1.181 | $1.0361 | $1.3015 | +156.75% |
| May, 2029 | $1.1093 | $1.0793 | $1.1992 | +141.15% |
| June, 2029 | $1.122 | $1.061 | $1.1295 | +143.91% |
| July, 2029 | $1.1441 | $0.9232 | $1.1827 | +148.71% |
| August, 2029 | $1.1458 | $1.0553 | $1.2139 | +149.10% |
| September, 2029 | $1.2074 | $1.1383 | $1.3208 | +162.48% |
| October, 2029 | $1.0995 | $1.0987 | $1.2186 | +139.02% |
| November, 2029 | $1.1119 | $0.9422 | $1.2018 | +141.71% |
| December, 2029 | $1.2033 | $1.0132 | $1.2033 | +161.60% |
Pharma-Bio Serv Inc Stock (PBSV) Price Forecast for 2030
Pharma-Bio Serv Inc Stock (PBSV) is expected to reach an average price of $1.1699 in 2030, with a high forecast of $1.3785 and a low forecast of $0.9613. This signifies an +154.33% surge from the last price of $0.46.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2195 | $1.0745 | $1.34 | +165.12% |
| February, 2030 | $1.2176 | $1.1763 | $1.2376 | +164.69% |
| March, 2030 | $1.1689 | $1.0999 | $1.2379 | +154.11% |
| April, 2030 | $1.0591 | $0.9613 | $1.2208 | +130.23% |
| May, 2030 | $1.1037 | $1.0323 | $1.2227 | +139.94% |
| June, 2030 | $1.1956 | $1.1767 | $1.3593 | +159.90% |
| July, 2030 | $1.1628 | $1.1374 | $1.2573 | +152.79% |
| August, 2030 | $1.2394 | $0.9803 | $1.2395 | +169.43% |
| September, 2030 | $1.2014 | $1.0506 | $1.2399 | +161.18% |
| October, 2030 | $1.204 | $1.1129 | $1.2716 | +161.73% |
| November, 2030 | $1.2758 | $1.2148 | $1.3785 | +177.35% |
| December, 2030 | $1.2077 | $1.1387 | $1.2767 | +162.54% |
0.02%
Cap:
|
Volume (24h):